2020 | 2030 | 2040 | |||||||
% | 95% CI (±) | % reduction from baseline | % | 95% CI (±) | % reduction from baseline | % | 95% CI (±) | % reduction from baseline | |
Baseline | 15.9 | 0.4 | – | 16.1 | 0.3 | – | 17.3 | 0.4 | – |
1. Population intervention | 15.5 | 0.4 | −3.0 | 13.3* | 0.3 | −17.6 | 13.8* | 0.3 | −20.5 |
2. Targeted prepregnancy | 15.5 | 0.3 | −2.8 | 15.3* | 0.3 | −5.2 | 16.2* | 0.4 | −6.2 |
3. Targeted interpregnancy reduction | 15.6 | 0.3 | −2.1 | 15.5* | 0.3 | −4.2 | 16.7* | 0.4 | −3.8 |
4. Combined population and targeted prepregnancy and interpregnancy | 13.6 | 0.4 | −14.4 | 11.5* | 0.3 | −28.8 | 11.8* | 0.3 | −32.1 |
*Significantly different from baseline at p<0.05.
HIP, hyperglycemia in pregnancy.